Historical record - last NADAC publication: 6/23/2021
Product Information
MUCINEX SINUS-MAX SEVERE CPLT is a brand product labeled by RB Health (US) LLC, priced at $0.5291 per EA under NDC 63824020144. Its NADAC has been published 325 times since Mar 30, 2016.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
MUCINEX SINUS-MAX SEVERE CPLT
Acetaminophen, Guaifenesin, and Phenylephrine HydrochlorideStrength
325; 200; 5 mg/1; mg/1; mg/1
Manufacturer
RB Health (US) LLCNDC
63824020144
Classification
Brand
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/23/2021
Active Ingredients
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/23/2012
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX SINUS-MAX SEVERE CPLT has been published 325 times since Mar 30, 2016, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5291 per EA |
|---|---|
| All-time high | $0.5549 (Dec 11, 2019) |
| All-time low | $0.4769 (Mar 30, 2016) |
| Median price | $0.5188 |
| Average price | $0.5172 |
| Largest weekly change | +9.0% (Apr 20, 2016) |
| Weeks tracked | 325 |
| Tracking since | Mar 30, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MUCINEX SINUS-MAX SEVERE CPLT?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX SINUS-MAX SEVERE CPLT, manufactured by RB Health (US) LLC, is $0.5291 per EA (NDC 63824020144), effective Jun 15, 2022.
How has the price of MUCINEX SINUS-MAX SEVERE CPLT changed over time?
Over the history we have for it, the NADAC for MUCINEX SINUS-MAX SEVERE CPLT has risen 10.9%. It has been tracked across 325 weekly CMS publications since Mar 30, 2016.
What are the highest and lowest recorded NADAC prices for MUCINEX SINUS-MAX SEVERE CPLT?
Since Mar 30, 2016, the NADAC for MUCINEX SINUS-MAX SEVERE CPLT has ranged from a low of $0.4769 (Mar 30, 2016) to a high of $0.5549 (Dec 11, 2019), with a median of $0.5188 per EA.
Are there cheaper alternatives to MUCINEX SINUS-MAX SEVERE CPLT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MUCINEX SINUS-MAX SEVERE CPLT, so no direct lower-cost alternative is listed.
Who manufactures MUCINEX SINUS-MAX SEVERE CPLT?
MUCINEX SINUS-MAX SEVERE CPLT (NDC 63824020144) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification